▶ 調査レポート

コンパニオンアニマル用医薬品・ワクチンの世界市場 2020年:企業別、地域別、種類・用途別

• 英文タイトル:Global Companion Animals Medicines and Vaccines Market 2020 by Company, Regions, Type and Application, Forecast to 2025

GlobalInfoResearchが調査・発行した産業分析レポートです。コンパニオンアニマル用医薬品・ワクチンの世界市場 2020年:企業別、地域別、種類・用途別 / Global Companion Animals Medicines and Vaccines Market 2020 by Company, Regions, Type and Application, Forecast to 2025 / D0804-15608資料のイメージです。• レポートコード:D0804-15608
• 出版社/出版日:GlobalInfoResearch / 2020年7月28日
※2025年版があります。お問い合わせください。

• レポート形態:英語、PDF、105ページ
• 納品方法:Eメール
• 産業分類:医薬品・治療
• 販売価格(消費税別)
  Single User¥487,200 (USD3,480)▷ お問い合わせ
  Multi User¥730,800 (USD5,220)▷ お問い合わせ
  Corporate User¥974,400 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、コンパニオンアニマル用医薬品・ワクチンの世界市場を広く調査・分析し、今後の市場展望をまとめております。コンパニオンアニマル用医薬品・ワクチンの種類別市場規模(医薬品、ワクチン)、用途別市場規模(犬、猫、その他)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。
・市場概要
・企業情報(販売量、市場シェア、製品概要、SWOT分析):Zoetis、Ceva、Elanco Animal Health、Boehringer Ingelheim、Dechra Veterinary Products、Merck Animal Health、Meiji、Virbac、Bayer Animal Health、Vetoquinol、Ouro Fino Saude、Parnell
・地域別グローバル市場分析 2015年-2020年
・コンパニオンアニマル用医薬品・ワクチンの北米市場(アメリカ、カナダ、メキシコ)
・コンパニオンアニマル用医薬品・ワクチンのヨーロッパ市場(ドイツ、イギリス、フランス、ロシア、イタリア)
・コンパニオンアニマル用医薬品・ワクチンのアジア市場(中国、日本、韓国、インド、東南アジア、オーストラリア)
・コンパニオンアニマル用医薬品・ワクチンの南米市場(ブラジル、アルゼンチン)
・コンパニオンアニマル用医薬品・ワクチンの中東・アフリカ市場(サウジアラビア、トルコ、エジプト、南アフリカ)
・種類別分析:医薬品、ワクチン
・用途別分析:犬、猫、その他
・地域別市場規模予測 2021年-2025年
・調査の結果・結論

Market Overview
The Companion Animals Medicines and Vaccines market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

The most likely (base case) scenario is that the global Companion Animals Medicines and Vaccines sales will be xx in 2020 from Companion Animals Medicines and Vaccines million in 2019, with a change xx% between 2019 and 2020. In addition, based on the latest study, it is to predict that the Covid-19 will be under control in key countries like the United States, Western Europe, East Asia, by the end of Q2 (June), and will resume normal production in Q3 and Q4, the global Companion Animals Medicines and Vaccines market size is expected to grow at xx% or more annually for the next five years.

This report also researches and evaluates the impact of Covid-19 outbreak on the Companion Animals Medicines and Vaccines industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on Companion Animals Medicines and Vaccines and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.).

Market segmentation
Companion Animals Medicines and Vaccines market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Companion Animals Medicines and Vaccines market has been segmented into:
Medicines
Vaccines

By Application, Companion Animals Medicines and Vaccines has been segmented into:
Dogs
Cats
Other

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Companion Animals Medicines and Vaccines market presented in the report. This section sheds light on the sales growth of different regional and country-level Companion Animals Medicines and Vaccines markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Companion Animals Medicines and Vaccines market.

The report offers in-depth assessment of the growth and other aspects of the Companion Animals Medicines and Vaccines market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Companion Animals Medicines and Vaccines Market Share Analysis
Companion Animals Medicines and Vaccines competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Companion Animals Medicines and Vaccines sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Companion Animals Medicines and Vaccines sales, revenue and market share for each player covered in this report.

The major players covered in Companion Animals Medicines and Vaccines are:
Zoetis
Ceva
Elanco Animal Health
Boehringer Ingelheim
Dechra Veterinary Products
Merck Animal Health
Meiji
Virbac
Bayer Animal Health
Vetoquinol
Ouro Fino Saude
Parnell
Among other players domestic and global, Companion Animals Medicines and Vaccines market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

レポート目次

1 Companion Animals Medicines and Vaccines Market Overview
1.1 Product Overview and Scope of Companion Animals Medicines and Vaccines
1.2 Classification of Companion Animals Medicines and Vaccines by Type
1.2.1 Global Companion Animals Medicines and Vaccines Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Companion Animals Medicines and Vaccines Revenue Market Share by Type in 2019
1.2.3 Medicines
1.2.4 Vaccines
1.3 Global Companion Animals Medicines and Vaccines Market by Application
1.3.1 Overview: Global Companion Animals Medicines and Vaccines Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Dogs
1.3.3 Cats
1.3.4 Other
1.4 Global Companion Animals Medicines and Vaccines Market by Regions
1.4.1 Global Companion Animals Medicines and Vaccines Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Companion Animals Medicines and Vaccines (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Companion Animals Medicines and Vaccines Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Companion Animals Medicines and Vaccines Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Companion Animals Medicines and Vaccines Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Companion Animals Medicines and Vaccines Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Companion Animals Medicines and Vaccines Status and Prospect (2015-2025)
1.5 COVID-19 Outbreak: Companion Animals Medicines and Vaccines Industry Impact
1.5.1 COVID-19 Potential Implications for the Companion Animals Medicines and Vaccines
1.5.1.1 Scenario One: Very Optimistic: COVID-19 has No Influence on Companion Animals Medicines and Vaccines
1.5.1.2 Scenario Two: Optimistic: COVID-19 Will Be Under Control by the End of April
1.5.1.3 Scenario Three: Gloomy: COVID-19 Will Be Under Control Between Q3 and Q4
1.5.1.4 Scenario Four: Most Likely: COVID-19 Will Be Under Control by the End of Q2
1.5.2 Opportunity Analysis in Covid-19 Crisis
1.5.3 Market Risk and Restraints
1.5.4 Market Driving Force
2 Company Profiles
2.1 Zoetis
2.1.1 Zoetis Details
2.1.2 Zoetis Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Zoetis SWOT Analysis
2.1.4 Zoetis Product and Services
2.1.5 Zoetis Companion Animals Medicines and Vaccines Revenue, Gross Margin and Market Share (2018-2019)
2.2 Ceva
2.2.1 Ceva Details
2.2.2 Ceva Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Ceva SWOT Analysis
2.2.4 Ceva Product and Services
2.2.5 Ceva Companion Animals Medicines and Vaccines Revenue, Gross Margin and Market Share (2018-2019)
2.3 Elanco Animal Health
2.3.1 Elanco Animal Health Details
2.3.2 Elanco Animal Health Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Elanco Animal Health SWOT Analysis
2.3.4 Elanco Animal Health Product and Services
2.3.5 Elanco Animal Health Companion Animals Medicines and Vaccines Revenue, Gross Margin and Market Share (2018-2019)
2.4 Boehringer Ingelheim
2.4.1 Boehringer Ingelheim Details
2.4.2 Boehringer Ingelheim Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Boehringer Ingelheim SWOT Analysis
2.4.4 Boehringer Ingelheim Product and Services
2.4.5 Boehringer Ingelheim Companion Animals Medicines and Vaccines Revenue, Gross Margin and Market Share (2018-2019)
2.5 Dechra Veterinary Products
2.5.1 Dechra Veterinary Products Details
2.5.2 Dechra Veterinary Products Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Dechra Veterinary Products SWOT Analysis
2.5.4 Dechra Veterinary Products Product and Services
2.5.5 Dechra Veterinary Products Companion Animals Medicines and Vaccines Revenue, Gross Margin and Market Share (2018-2019)
2.6 Merck Animal Health
2.6.1 Merck Animal Health Details
2.6.2 Merck Animal Health Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Merck Animal Health Product and Services
2.6.4 Merck Animal Health Companion Animals Medicines and Vaccines Revenue, Gross Margin and Market Share (2018-2019)
2.7 Meiji
2.7.1 Meiji Details
2.7.2 Meiji Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Meiji Product and Services
2.7.4 Meiji Companion Animals Medicines and Vaccines Revenue, Gross Margin and Market Share (2018-2019)
2.8 Virbac
2.8.1 Virbac Details
2.8.2 Virbac Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Virbac Product and Services
2.8.4 Virbac Companion Animals Medicines and Vaccines Revenue, Gross Margin and Market Share (2018-2019)
2.9 Bayer Animal Health
2.9.1 Bayer Animal Health Details
2.9.2 Bayer Animal Health Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Bayer Animal Health Product and Services
2.9.4 Bayer Animal Health Companion Animals Medicines and Vaccines Revenue, Gross Margin and Market Share (2018-2019)
2.10 Vetoquinol
2.10.1 Vetoquinol Details
2.10.2 Vetoquinol Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Vetoquinol Product and Services
2.10.4 Vetoquinol Companion Animals Medicines and Vaccines Revenue, Gross Margin and Market Share (2018-2019)
2.11 Ouro Fino Saude
2.11.1 Ouro Fino Saude Details
2.11.2 Ouro Fino Saude Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Ouro Fino Saude Product and Services
2.11.4 Ouro Fino Saude Companion Animals Medicines and Vaccines Revenue, Gross Margin and Market Share (2018-2019)
2.12 Parnell
2.12.1 Parnell Details
2.12.2 Parnell Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Parnell Product and Services
2.12.4 Parnell Companion Animals Medicines and Vaccines Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Companion Animals Medicines and Vaccines Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Companion Animals Medicines and Vaccines Players Market Share
3.2.2 Top 10 Companion Animals Medicines and Vaccines Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Companion Animals Medicines and Vaccines Revenue and Market Share by Regions
4.2 North America Companion Animals Medicines and Vaccines Revenue and Growth Rate (2015-2020)
4.3 Europe Companion Animals Medicines and Vaccines Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Companion Animals Medicines and Vaccines Revenue and Growth Rate (2015-2020)
4.5 South America Companion Animals Medicines and Vaccines Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Companion Animals Medicines and Vaccines Revenue and Growth Rate (2015-2020)
5 North America Companion Animals Medicines and Vaccines Revenue by Countries
5.1 North America Companion Animals Medicines and Vaccines Revenue by Countries (2015-2020)
5.2 USA Companion Animals Medicines and Vaccines Revenue and Growth Rate (2015-2020)
5.3 Canada Companion Animals Medicines and Vaccines Revenue and Growth Rate (2015-2020)
5.4 Mexico Companion Animals Medicines and Vaccines Revenue and Growth Rate (2015-2020)
6 Europe Companion Animals Medicines and Vaccines Revenue by Countries
6.1 Europe Companion Animals Medicines and Vaccines Revenue by Countries (2015-2020)
6.2 Germany Companion Animals Medicines and Vaccines Revenue and Growth Rate (2015-2020)
6.3 UK Companion Animals Medicines and Vaccines Revenue and Growth Rate (2015-2020)
6.4 France Companion Animals Medicines and Vaccines Revenue and Growth Rate (2015-2020)
6.5 Russia Companion Animals Medicines and Vaccines Revenue and Growth Rate (2015-2020)
6.6 Italy Companion Animals Medicines and Vaccines Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Companion Animals Medicines and Vaccines Revenue by Countries
7.1 Asia-Pacific Companion Animals Medicines and Vaccines Revenue by Countries (2015-2020)
7.2 China Companion Animals Medicines and Vaccines Revenue and Growth Rate (2015-2020)
7.3 Japan Companion Animals Medicines and Vaccines Revenue and Growth Rate (2015-2020)
7.4 Korea Companion Animals Medicines and Vaccines Revenue and Growth Rate (2015-2020)
7.5 India Companion Animals Medicines and Vaccines Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Companion Animals Medicines and Vaccines Revenue and Growth Rate (2015-2020)
8 South America Companion Animals Medicines and Vaccines Revenue by Countries
8.1 South America Companion Animals Medicines and Vaccines Revenue by Countries (2015-2020)
8.2 Brazil Companion Animals Medicines and Vaccines Revenue and Growth Rate (2015-2020)
8.3 Argentina Companion Animals Medicines and Vaccines Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Companion Animals Medicines and Vaccines by Countries
9.1 Middle East & Africa Companion Animals Medicines and Vaccines Revenue by Countries (2015-2020)
9.2 Saudi Arabia Companion Animals Medicines and Vaccines Revenue and Growth Rate (2015-2020)
9.3 UAE Companion Animals Medicines and Vaccines Revenue and Growth Rate (2015-2020)
9.4 Egypt Companion Animals Medicines and Vaccines Revenue and Growth Rate (2015-2020)
9.5 South Africa Companion Animals Medicines and Vaccines Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Companion Animals Medicines and Vaccines Revenue and Market Share by Type (2015-2020)
10.2 Global Companion Animals Medicines and Vaccines Market Forecast by Type (2019-2024)
10.3 Medicines Revenue Growth Rate (2015-2025)
10.4 Vaccines Revenue Growth Rate (2015-2025)
11 Global Companion Animals Medicines and Vaccines Market Segment by Application
11.1 Global Companion Animals Medicines and Vaccines Revenue Market Share by Application (2015-2020)
11.2 Companion Animals Medicines and Vaccines Market Forecast by Application (2019-2024)
11.3 Dogs Revenue Growth (2015-2020)
11.4 Cats Revenue Growth (2015-2020)
11.5 Other Revenue Growth (2015-2020)
12 Global Companion Animals Medicines and Vaccines Market Size Forecast (2021-2025)
12.1 Global Companion Animals Medicines and Vaccines Market Size Forecast (2021-2025)
12.2 Global Companion Animals Medicines and Vaccines Market Forecast by Regions (2021-2025)
12.3 North America Companion Animals Medicines and Vaccines Revenue Market Forecast (2021-2025)
12.4 Europe Companion Animals Medicines and Vaccines Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Companion Animals Medicines and Vaccines Revenue Market Forecast (2021-2025)
12.6 South America Companion Animals Medicines and Vaccines Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Companion Animals Medicines and Vaccines Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables
Table 1. Global Companion Animals Medicines and Vaccines Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Companion Animals Medicines and Vaccines by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Companion Animals Medicines and Vaccines Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Companion Animals Medicines and Vaccines Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Global Companion Animals Medicines and Vaccines Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. Zoetis Corporate Information, Location and Competitors
Table 7. Zoetis Companion Animals Medicines and Vaccines Major Business
Table 8. Zoetis Companion Animals Medicines and Vaccines Total Revenue (USD Million) (2017-2018)
Table 9. Zoetis SWOT Analysis
Table 10. Zoetis Companion Animals Medicines and Vaccines Product and Solutions
Table 11. Zoetis Companion Animals Medicines and Vaccines Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 12. Ceva Corporate Information, Location and Competitors
Table 13. Ceva Companion Animals Medicines and Vaccines Major Business
Table 14. Ceva Companion Animals Medicines and Vaccines Total Revenue (USD Million) (2018-2019)
Table 15. Ceva SWOT Analysis
Table 16. Ceva Companion Animals Medicines and Vaccines Product and Solutions
Table 17. Ceva Companion Animals Medicines and Vaccines Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 18. Elanco Animal Health Corporate Information, Location and Competitors
Table 19. Elanco Animal Health Companion Animals Medicines and Vaccines Major Business
Table 20. Elanco Animal Health Companion Animals Medicines and Vaccines Total Revenue (USD Million) (2017-2018)
Table 21. Elanco Animal Health SWOT Analysis
Table 22. Elanco Animal Health Companion Animals Medicines and Vaccines Product and Solutions
Table 23. Elanco Animal Health Companion Animals Medicines and Vaccines Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 24. Boehringer Ingelheim Corporate Information, Location and Competitors
Table 25. Boehringer Ingelheim Companion Animals Medicines and Vaccines Major Business
Table 26. Boehringer Ingelheim Companion Animals Medicines and Vaccines Total Revenue (USD Million) (2017-2018)
Table 27. Boehringer Ingelheim SWOT Analysis
Table 28. Boehringer Ingelheim Companion Animals Medicines and Vaccines Product and Solutions
Table 29. Boehringer Ingelheim Companion Animals Medicines and Vaccines Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 30. Dechra Veterinary Products Corporate Information, Location and Competitors
Table 31. Dechra Veterinary Products Companion Animals Medicines and Vaccines Major Business
Table 32. Dechra Veterinary Products Companion Animals Medicines and Vaccines Total Revenue (USD Million) (2017-2018)
Table 33. Dechra Veterinary Products SWOT Analysis
Table 34. Dechra Veterinary Products Companion Animals Medicines and Vaccines Product and Solutions
Table 35. Dechra Veterinary Products Companion Animals Medicines and Vaccines Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 36. Merck Animal Health Corporate Information, Location and Competitors
Table 37. Merck Animal Health Companion Animals Medicines and Vaccines Major Business
Table 38. Merck Animal Health Companion Animals Medicines and Vaccines Total Revenue (USD Million) (2017-2018)
Table 39. Merck Animal Health SWOT Analysis
Table 40. Merck Animal Health Companion Animals Medicines and Vaccines Product and Solutions
Table 41. Merck Animal Health Companion Animals Medicines and Vaccines Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 42. Meiji Corporate Information, Location and Competitors
Table 43. Meiji Companion Animals Medicines and Vaccines Major Business
Table 44. Meiji Companion Animals Medicines and Vaccines Total Revenue (USD Million) (2017-2018)
Table 45. Meiji SWOT Analysis
Table 46. Meiji Companion Animals Medicines and Vaccines Product and Solutions
Table 47. Meiji Companion Animals Medicines and Vaccines Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 48. Virbac Corporate Information, Location and Competitors
Table 49. Virbac Companion Animals Medicines and Vaccines Major Business
Table 50. Virbac Companion Animals Medicines and Vaccines Total Revenue (USD Million) (2017-2018)
Table 51. Virbac SWOT Analysis
Table 52. Virbac Companion Animals Medicines and Vaccines Product and Solutions
Table 53. Virbac Companion Animals Medicines and Vaccines Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 54. Bayer Animal Health Corporate Information, Location and Competitors
Table 55. Bayer Animal Health Companion Animals Medicines and Vaccines Major Business
Table 56. Bayer Animal Health Companion Animals Medicines and Vaccines Total Revenue (USD Million) (2017-2018)
Table 57. Bayer Animal Health SWOT Analysis
Table 58. Bayer Animal Health Companion Animals Medicines and Vaccines Product and Solutions
Table 59. Bayer Animal Health Companion Animals Medicines and Vaccines Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 60. Vetoquinol Corporate Information, Location and Competitors
Table 61. Vetoquinol Companion Animals Medicines and Vaccines Major Business
Table 62. Vetoquinol Companion Animals Medicines and Vaccines Total Revenue (USD Million) (2017-2018)
Table 63. Vetoquinol SWOT Analysis
Table 64. Vetoquinol Companion Animals Medicines and Vaccines Product and Solutions
Table 65. Vetoquinol Companion Animals Medicines and Vaccines Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 66. Ouro Fino Saude Corporate Information, Location and Competitors
Table 67. Ouro Fino Saude Companion Animals Medicines and Vaccines Major Business
Table 68. Ouro Fino Saude Companion Animals Medicines and Vaccines Total Revenue (USD Million) (2017-2018)
Table 69. Ouro Fino Saude SWOT Analysis
Table 70. Ouro Fino Saude Companion Animals Medicines and Vaccines Product and Solutions
Table 71. Ouro Fino Saude Companion Animals Medicines and Vaccines Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 72. Parnell Corporate Information, Location and Competitors
Table 73. Parnell Companion Animals Medicines and Vaccines Major Business
Table 74. Parnell Companion Animals Medicines and Vaccines Total Revenue (USD Million) (2017-2018)
Table 75. Parnell SWOT Analysis
Table 76. Parnell Companion Animals Medicines and Vaccines Product and Solutions
Table 77. Parnell Companion Animals Medicines and Vaccines Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 78. Global Companion Animals Medicines and Vaccines Revenue (Million USD) by Players (2015-2020)
Table 79. Global Companion Animals Medicines and Vaccines Revenue Share by Players (2015-2020)
Table 80. Global Companion Animals Medicines and Vaccines Revenue (Million USD) by Regions (2015-2020)
Table 81. Global Companion Animals Medicines and Vaccines Revenue Market Share by Regions (2015-2020)
Table 82. North America Companion Animals Medicines and Vaccines Revenue by Countries (2015-2020)
Table 83. North America Companion Animals Medicines and Vaccines Revenue Market Share by Countries (2015-2020)
Table 84. Europe Companion Animals Medicines and Vaccines Revenue (Million USD) by Countries (2015-2020)
Table 85. Asia-Pacific Companion Animals Medicines and Vaccines Revenue (Million USD) by Countries (2015-2020)
Table 86. South America Companion Animals Medicines and Vaccines Revenue by Countries (2015-2020)
Table 87. South America Companion Animals Medicines and Vaccines Revenue Market Share by Countries (2015-2020)
Table 88. Middle East and Africa Companion Animals Medicines and Vaccines Revenue (Million USD) by Countries (2015-2020)
Table 89. Middle East and Africa Companion Animals Medicines and Vaccines Revenue Market Share by Countries (2015-2020)
Table 90. Global Companion Animals Medicines and Vaccines Revenue (Million USD) by Type (2015-2020)
Table 91. Global Companion Animals Medicines and Vaccines Revenue Share by Type (2015-2020)
Table 92. Global Companion Animals Medicines and Vaccines Revenue Forecast by Type (2021-2025)
Table 93. Global Companion Animals Medicines and Vaccines Revenue by Application (2015-2020)
Table 94. Global Companion Animals Medicines and Vaccines Revenue Share by Application (2015-2020)
Table 95. Global Companion Animals Medicines and Vaccines Revenue Forecast by Application (2021-2025)
Table 96. Global Companion Animals Medicines and Vaccines Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Companion Animals Medicines and Vaccines Picture
Figure 2. Global Companion Animals Medicines and Vaccines Revenue Market Share by Type in 2019
Figure 3. Medicines Picture
Figure 4. Vaccines Picture
Figure 5. Companion Animals Medicines and Vaccines Revenue Market Share by Application in 2019
Figure 6. Dogs Picture
Figure 7. Cats Picture
Figure 8. Other Picture
Figure 9. Global Companion Animals Medicines and Vaccines Revenue (USD Million) and Growth Rate (2015-2025)
Figure 10. North America Companion Animals Medicines and Vaccines Revenue (Million USD) and Growth Rate (2015-2025)
Figure 11. Europe Companion Animals Medicines and Vaccines Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Asia-Pacific Companion Animals Medicines and Vaccines Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. South America Companion Animals Medicines and Vaccines Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Middle East and Africa Companion Animals Medicines and Vaccines Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Global Companion Animals Medicines and Vaccines Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Companion Animals Medicines and Vaccines Revenue Share by Players in 2019
Figure 17. Global Top 5 Players Companion Animals Medicines and Vaccines Revenue Market Share in 2019
Figure 18. Global Top 10 Players Companion Animals Medicines and Vaccines Revenue Market Share in 2019
Figure 19. Key Players Market Share Trend
Figure 20. Global Companion Animals Medicines and Vaccines Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 21. Global Companion Animals Medicines and Vaccines Revenue Market Share by Regions (2015-2020)
Figure 22. Global Companion Animals Medicines and Vaccines Revenue Market Share by Regions in 2018
Figure 23. North America Companion Animals Medicines and Vaccines Revenue and Growth Rate (2015-2020)
Figure 24. Europe Companion Animals Medicines and Vaccines Revenue and Growth Rate (2015-2020)
Figure 25. Asia-Pacific Companion Animals Medicines and Vaccines Revenue and Growth Rate (2015-2020)
Figure 26. South America Companion Animals Medicines and Vaccines Revenue and Growth Rate (2015-2020)
Figure 27. Middle East and Africa Companion Animals Medicines and Vaccines Revenue and Growth Rate (2015-2020)
Figure 28. North America Companion Animals Medicines and Vaccines Revenue Market Share by Countries (2015-2020)
Figure 29. North America Companion Animals Medicines and Vaccines Revenue Market Share by Countries in 2019
Figure 30. USA Companion Animals Medicines and Vaccines Revenue and Growth Rate (2015-2020)
Figure 31. Canada Companion Animals Medicines and Vaccines Revenue and Growth Rate (2015-2020)
Figure 32. Mexico Companion Animals Medicines and Vaccines Revenue and Growth Rate (2015-2020)
Figure 33. Europe Companion Animals Medicines and Vaccines Revenue Market Share by Countries (2015-2020)
Figure 34. Europe Companion Animals Medicines and Vaccines Revenue Market Share by Countries in 2019
Figure 35. Germany Companion Animals Medicines and Vaccines Revenue and Growth Rate (2015-2020)
Figure 36. UK Companion Animals Medicines and Vaccines Revenue and Growth Rate (2015-2020)
Figure 37. France Companion Animals Medicines and Vaccines Revenue and Growth Rate (2015-2020)
Figure 38. Russia Companion Animals Medicines and Vaccines Revenue and Growth Rate (2015-2020)
Figure 39. Italy Companion Animals Medicines and Vaccines Revenue and Growth Rate (2015-2020)
Figure 40. Asia-Pacific Companion Animals Medicines and Vaccines Revenue Market Share by Countries (2015-2020)
Figure 41. Asia-Pacific Companion Animals Medicines and Vaccines Revenue Market Share by Countries in 2019
Figure 42. China Companion Animals Medicines and Vaccines Revenue and Growth Rate (2015-2020)
Figure 43. Japan Companion Animals Medicines and Vaccines Revenue and Growth Rate (2015-2020)
Figure 44. Korea Companion Animals Medicines and Vaccines Revenue and Growth Rate (2015-2020)
Figure 45. India Companion Animals Medicines and Vaccines Revenue and Growth Rate (2015-2020)
Figure 46. Southeast Asia Companion Animals Medicines and Vaccines Revenue and Growth Rate (2015-2020)
Figure 47. South America Companion Animals Medicines and Vaccines Revenue Market Share by Countries (2015-2020)
Figure 48. South America Companion Animals Medicines and Vaccines Revenue Market Share by Countries in 2019
Figure 49. Brazil Companion Animals Medicines and Vaccines Revenue and Growth Rate (2015-2020)
Figure 50. Argentina Companion Animals Medicines and Vaccines Revenue and Growth Rate (2015-2020)
Figure 51. Middle East and Africa Companion Animals Medicines and Vaccines Revenue Market Share by Countries (2015-2020)
Figure 52. Middle East and Africa Companion Animals Medicines and Vaccines Revenue Market Share by Countries in 2019
Figure 53. Saudi Arabia Companion Animals Medicines and Vaccines Revenue and Growth Rate (2015-2020)
Figure 54. UAE Companion Animals Medicines and Vaccines Revenue and Growth Rate (2015-2020)
Figure 55. Egypt Companion Animals Medicines and Vaccines Revenue and Growth Rate (2015-2020)
Figure 56. South Africa Companion Animals Medicines and Vaccines Revenue and Growth Rate (2015-2020)
Figure 57. Global Companion Animals Medicines and Vaccines Revenue Share by Type (2015-2020)
Figure 58. Global Companion Animals Medicines and Vaccines Revenue Share by Type in 2019
Figure 59. Global Companion Animals Medicines and Vaccines Market Share Forecast by Type (2021-2025)
Figure 60. Global Medicines Revenue Growth Rate (2015-2020)
Figure 61. Global Vaccines Revenue Growth Rate (2015-2020)
Figure 62. Global Companion Animals Medicines and Vaccines Revenue Share by Application (2015-2020)
Figure 63. Global Companion Animals Medicines and Vaccines Revenue Share by Application in 2019
Figure 64. Global Companion Animals Medicines and Vaccines Market Share Forecast by Application (2021-2025)
Figure 65. Global Dogs Revenue Growth Rate (2015-2020)
Figure 66. Global Cats Revenue Growth Rate (2015-2020)
Figure 67. Global Other Revenue Growth Rate (2015-2020)
Figure 68. Global Companion Animals Medicines and Vaccines Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 69. Global Companion Animals Medicines and Vaccines Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 70. Global Companion Animals Medicines and Vaccines Revenue Market Share Forecast by Regions (2021-2025)
Figure 71. North America Companion Animals Medicines and Vaccines Revenue Market Forecast (2021-2025)
Figure 72. Europe Companion Animals Medicines and Vaccines Revenue Market Forecast (2021-2025)
Figure 73. Asia-Pacific Companion Animals Medicines and Vaccines Revenue Market Forecast (2021-2025)
Figure 74. South America Companion Animals Medicines and Vaccines Revenue Market Forecast (2021-2025)
Figure 75. Middle East and Africa Companion Animals Medicines and Vaccines Revenue Market Forecast (2021-2025)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel